Stockreport
Veracyte's (VCYT) CEO Bonnie Anderson on Q1 2017 Results - Earnings Call Transcript [Seeking Alpha]
Last veracyte earnings: 10/29 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations: investor.veracyte.com/investor-relations
PDF
Veracyte, Inc. (NASDAQ: VCYT ) Q1 2017 Results Earnings Conference Call May 3, 2017, 04:30 PM ET Executives Bonnie Anderson - Chief Executive Officer and Chairman of the Board Keith Kennedy - Chief Financial Officer Christopher Hall - President and Chief Operating Officer Analysts Puneet Souda - LEERINK Partners LLC Amanda Murphy - William Blair & Company, LLC Alexander Nowak - Piper Jaffray & Co. Bryan Brokmeier - Cantor Fitzgerald Carolina Ibanez-Ventoso - Janney Montgomery Scott LLC Operator Good afternoon, ladies and gentlemen, and welcome to the Veracyte first quarter 2017 financial results conference call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that. [Operator Instructions]. As a reminder, this conference call is being recorded. I’d now like to turn the conference over to your host, Ms. Bonnie Anderson, Chief Executive Officer and Chairman
[Read more]
| IMPACT SNAPSHOT | EVENT TIME: | VCYT | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| LAST PRICE | ||
| VWAP | ||
|
High:
|
MAX UP |
High:
|
|
Low:
|
MAX DOWN |
Low:
|
|
%
|
POST NEWS RANGE |
%
|
|
|
PRICE CHANGE |
|
|
|
PRICE CHANGE PERCENTAGE |
|
|
|
S&P 500 (SPX) |
|
|
%
|
VOLUME RATIO |
%
|
| VOLUME (SHARES) | ||
| TICKS | ||
|
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
VCYT alerts
VCYT alerts
from News Quantified
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VCYT alerts
High impacting VERACYTE news events
Weekly update
A roundup of the hottest topics
VCYT
NEWS
NEWS
- Veracyte to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum[Business Wire]
- Veracyte Announces Publication of Data Demonstrating “Real World” Performance of Afirma GSC in Thyroid Cancer Diagnosis[Business Wire]
- Veracyte Inc (NASDAQ: VCYT) had its "outperform" rating re-affirmed by analysts at William Blair.[MarketBeat]
- Veracyte Inc (NASDAQ: VCYT) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "strong-buy" rating. They now have a $13.00 price target on the stock.[MarketBeat]
- Veracyte Inc (NASDAQ: VCYT) was upgraded by analysts at Janney Montgomery Scott from a "neutral" rating to a "buy" rating.[MarketBeat]
- More
VCYT
SEC Filings
SEC Filings
- 11/13/18 - Form 4
- 11/1/18 - Form 4
- 10/29/18 - Form 10-Q
- VCYT's page on the SEC website
- More